Global Flu RNA Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Flu RNA Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Flu RNA Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Flu RNA Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Flu RNA Vaccines Segment by Type

2.2.1 Non-Replicating mRNA

2.2.2 In Vivo Self-Replicating mRNA

2.2.3 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine

2.2.4 Others

2.3 Flu RNA Vaccines Sales by Type

2.3.1 Global Flu RNA Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Flu RNA Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Flu RNA Vaccines Sale Price by Type (2017-2022)

2.4 Flu RNA Vaccines Segment by Application

2.4.1 Hospitals

2.4.2 Vaccination Center

2.4.3 Specialized Clinics

2.4.4 Hospital Pharmacy

2.4.5 Others

2.5 Flu RNA Vaccines Sales by Application

2.5.1 Global Flu RNA Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Flu RNA Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Flu RNA Vaccines Sale Price by Application (2017-2022)

3 Global Flu RNA Vaccines by Company

3.1 Global Flu RNA Vaccines Breakdown Data by Company

3.1.1 Global Flu RNA Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Flu RNA Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Flu RNA Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Flu RNA Vaccines Revenue by Company (2020-2022)

3.2.2 Global Flu RNA Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Flu RNA Vaccines Sale Price by Company

3.4 Key Manufacturers Flu RNA Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Flu RNA Vaccines Product Location Distribution

3.4.2 Players Flu RNA Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Flu RNA Vaccines by Geographic Region

4.1 World Historic Flu RNA Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Flu RNA Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Flu RNA Vaccines Annual Revenue by Geographic Region

4.2 World Historic Flu RNA Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Flu RNA Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Flu RNA Vaccines Annual Revenue by Country/Region

4.3 Americas Flu RNA Vaccines Sales Growth

4.4 APAC Flu RNA Vaccines Sales Growth

4.5 Europe Flu RNA Vaccines Sales Growth

4.6 Middle East & Africa Flu RNA Vaccines Sales Growth

5 Americas

5.1 Americas Flu RNA Vaccines Sales by Country

5.1.1 Americas Flu RNA Vaccines Sales by Country (2017-2022)

5.1.2 Americas Flu RNA Vaccines Revenue by Country (2017-2022)

5.2 Americas Flu RNA Vaccines Sales by Type

5.3 Americas Flu RNA Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Flu RNA Vaccines Sales by Region

6.1.1 APAC Flu RNA Vaccines Sales by Region (2017-2022)

6.1.2 APAC Flu RNA Vaccines Revenue by Region (2017-2022)

6.2 APAC Flu RNA Vaccines Sales by Type

6.3 APAC Flu RNA Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Flu RNA Vaccines by Country

7.1.1 Europe Flu RNA Vaccines Sales by Country (2017-2022)

7.1.2 Europe Flu RNA Vaccines Revenue by Country (2017-2022)

7.2 Europe Flu RNA Vaccines Sales by Type

7.3 Europe Flu RNA Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Flu RNA Vaccines by Country

8.1.1 Middle East & Africa Flu RNA Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Flu RNA Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Flu RNA Vaccines Sales by Type

8.3 Middle East & Africa Flu RNA Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Flu RNA Vaccines

10.3 Manufacturing Process Analysis of Flu RNA Vaccines

10.4 Industry Chain Structure of Flu RNA Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Flu RNA Vaccines Distributors

11.3 Flu RNA Vaccines Customer

12 World Forecast Review for Flu RNA Vaccines by Geographic Region

12.1 Global Flu RNA Vaccines Market Size Forecast by Region

12.1.1 Global Flu RNA Vaccines Forecast by Region (2023-2028)

12.1.2 Global Flu RNA Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Flu RNA Vaccines Forecast by Type

12.7 Global Flu RNA Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur Inc.

13.1.1 Sanofi Pasteur Inc. Company Information

13.1.2 Sanofi Pasteur Inc. Flu RNA Vaccines Product Offered

13.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Inc. Main Business Overview

13.1.5 Sanofi Pasteur Inc. Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Flu RNA Vaccines Product Offered

13.2.3 AstraZeneca Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 CSL Ltd.

13.3.1 CSL Ltd. Company Information

13.3.2 CSL Ltd. Flu RNA Vaccines Product Offered

13.3.3 CSL Ltd. Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Ltd. Main Business Overview

13.3.5 CSL Ltd. Latest Developments

13.4 Abbott

13.4.1 Abbott Company Information

13.4.2 Abbott Flu RNA Vaccines Product Offered

13.4.3 Abbott Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Main Business Overview

13.4.5 Abbott Latest Developments

13.5 GlaxoSmithKline Plc.

13.5.1 GlaxoSmithKline Plc. Company Information

13.5.2 GlaxoSmithKline Plc. Flu RNA Vaccines Product Offered

13.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc. Main Business Overview

13.5.5 GlaxoSmithKline Plc. Latest Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Serum Institute of India Pvt. Ltd. Company Information

13.6.2 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Offered

13.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Serum Institute of India Pvt. Ltd. Main Business Overview

13.6.5 Serum Institute of India Pvt. Ltd. Latest Developments

13.7 Pfizer

13.7.1 Pfizer Company Information

13.7.2 Pfizer Flu RNA Vaccines Product Offered

13.7.3 Pfizer Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Main Business Overview

13.7.5 Pfizer Latest Developments

13.8 BioNTech

13.8.1 BioNTech Company Information

13.8.2 BioNTech Flu RNA Vaccines Product Offered

13.8.3 BioNTech Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 BioNTech Main Business Overview

13.8.5 BioNTech Latest Developments

13.9 F.Hoffman La Roche Ltd

13.9.1 F.Hoffman La Roche Ltd Company Information

13.9.2 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Offered

13.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 F.Hoffman La Roche Ltd Main Business Overview

13.9.5 F.Hoffman La Roche Ltd Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Flu RNA Vaccines Product Offered

13.10.3 Novartis Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Sinnovac Biotech Ltd

13.11.1 Sinnovac Biotech Ltd Company Information

13.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Product Offered

13.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sinnovac Biotech Ltd Main Business Overview

13.11.5 Sinnovac Biotech Ltd Latest Developments

13.12 Moderna Therapeutics

13.12.1 Moderna Therapeutics Company Information

13.12.2 Moderna Therapeutics Flu RNA Vaccines Product Offered

13.12.3 Moderna Therapeutics Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Moderna Therapeutics Main Business Overview

13.12.5 Moderna Therapeutics Latest Developments

13.13 CureVac

13.13.1 CureVac Company Information

13.13.2 CureVac Flu RNA Vaccines Product Offered

13.13.3 CureVac Flu RNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 CureVac Main Business Overview

13.13.5 CureVac Latest Developments

14 Research Findings and Conclusion

Table 1. Flu RNA Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Flu RNA Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Non-Replicating mRNA

Table 4. Major Players of In Vivo Self-Replicating mRNA

Table 5. Major Players of In Vitro Dendritic Cell Non-Replicating mRNA Vaccine

Table 6. Major Players of Others

Table 7. Global Flu RNA Vaccines Sales by Type (2017-2022) & (K Units)

Table 8. Global Flu RNA Vaccines Sales Market Share by Type (2017-2022)

Table 9. Global Flu RNA Vaccines Revenue by Type (2017-2022) & ($ million)

Table 10. Global Flu RNA Vaccines Revenue Market Share by Type (2017-2022)

Table 11. Global Flu RNA Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Flu RNA Vaccines Sales by Application (2017-2022) & (K Units)

Table 13. Global Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Table 14. Global Flu RNA Vaccines Revenue by Application (2017-2022)

Table 15. Global Flu RNA Vaccines Revenue Market Share by Application (2017-2022)

Table 16. Global Flu RNA Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Flu RNA Vaccines Sales by Company (2020-2022) & (K Units)

Table 18. Global Flu RNA Vaccines Sales Market Share by Company (2020-2022)

Table 19. Global Flu RNA Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Flu RNA Vaccines Revenue Market Share by Company (2020-2022)

Table 21. Global Flu RNA Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Flu RNA Vaccines Producing Area Distribution and Sales Area

Table 23. Players Flu RNA Vaccines Products Offered

Table 24. Flu RNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Flu RNA Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Flu RNA Vaccines Sales Market Share Geographic Region (2017-2022)

Table 29. Global Flu RNA Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Flu RNA Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Flu RNA Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Flu RNA Vaccines Sales Market Share by Country/Region (2017-2022)

Table 33. Global Flu RNA Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Flu RNA Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Flu RNA Vaccines Sales by Country (2017-2022) & (K Units)

Table 36. Americas Flu RNA Vaccines Sales Market Share by Country (2017-2022)

Table 37. Americas Flu RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Flu RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 39. Americas Flu RNA Vaccines Sales by Type (2017-2022) & (K Units)

Table 40. Americas Flu RNA Vaccines Sales Market Share by Type (2017-2022)

Table 41. Americas Flu RNA Vaccines Sales by Application (2017-2022) & (K Units)

Table 42. Americas Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Table 43. APAC Flu RNA Vaccines Sales by Region (2017-2022) & (K Units)

Table 44. APAC Flu RNA Vaccines Sales Market Share by Region (2017-2022)

Table 45. APAC Flu RNA Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Flu RNA Vaccines Revenue Market Share by Region (2017-2022)

Table 47. APAC Flu RNA Vaccines Sales by Type (2017-2022) & (K Units)

Table 48. APAC Flu RNA Vaccines Sales Market Share by Type (2017-2022)

Table 49. APAC Flu RNA Vaccines Sales by Application (2017-2022) & (K Units)

Table 50. APAC Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Table 51. Europe Flu RNA Vaccines Sales by Country (2017-2022) & (K Units)

Table 52. Europe Flu RNA Vaccines Sales Market Share by Country (2017-2022)

Table 53. Europe Flu RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Flu RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 55. Europe Flu RNA Vaccines Sales by Type (2017-2022) & (K Units)

Table 56. Europe Flu RNA Vaccines Sales Market Share by Type (2017-2022)

Table 57. Europe Flu RNA Vaccines Sales by Application (2017-2022) & (K Units)

Table 58. Europe Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Flu RNA Vaccines Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Flu RNA Vaccines Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Flu RNA Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Flu RNA Vaccines Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Flu RNA Vaccines Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Flu RNA Vaccines Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Flu RNA Vaccines Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Flu RNA Vaccines

Table 68. Key Market Challenges & Risks of Flu RNA Vaccines

Table 69. Key Industry Trends of Flu RNA Vaccines

Table 70. Flu RNA Vaccines Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Flu RNA Vaccines Distributors List

Table 73. Flu RNA Vaccines Customer List

Table 74. Global Flu RNA Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Flu RNA Vaccines Sales Market Forecast by Region

Table 76. Global Flu RNA Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Flu RNA Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Flu RNA Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Flu RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Flu RNA Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Flu RNA Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Flu RNA Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Flu RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Flu RNA Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Flu RNA Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Flu RNA Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Flu RNA Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Flu RNA Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Flu RNA Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Flu RNA Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Flu RNA Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Flu RNA Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Flu RNA Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sanofi Pasteur Inc. Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi Pasteur Inc. Flu RNA Vaccines Product Offered

Table 96. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Sanofi Pasteur Inc. Main Business

Table 98. Sanofi Pasteur Inc. Latest Developments

Table 99. AstraZeneca Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Flu RNA Vaccines Product Offered

Table 101. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. AstraZeneca Main Business

Table 103. AstraZeneca Latest Developments

Table 104. CSL Ltd. Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 105. CSL Ltd. Flu RNA Vaccines Product Offered

Table 106. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. CSL Ltd. Main Business

Table 108. CSL Ltd. Latest Developments

Table 109. Abbott Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 110. Abbott Flu RNA Vaccines Product Offered

Table 111. Abbott Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Abbott Main Business

Table 113. Abbott Latest Developments

Table 114. GlaxoSmithKline Plc. Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 115. GlaxoSmithKline Plc. Flu RNA Vaccines Product Offered

Table 116. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. GlaxoSmithKline Plc. Main Business

Table 118. GlaxoSmithKline Plc. Latest Developments

Table 119. Serum Institute of India Pvt. Ltd. Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 120. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Offered

Table 121. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Serum Institute of India Pvt. Ltd. Main Business

Table 123. Serum Institute of India Pvt. Ltd. Latest Developments

Table 124. Pfizer Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 125. Pfizer Flu RNA Vaccines Product Offered

Table 126. Pfizer Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Pfizer Main Business

Table 128. Pfizer Latest Developments

Table 129. BioNTech Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 130. BioNTech Flu RNA Vaccines Product Offered

Table 131. BioNTech Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. BioNTech Main Business

Table 133. BioNTech Latest Developments

Table 134. F.Hoffman La Roche Ltd Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 135. F.Hoffman La Roche Ltd Flu RNA Vaccines Product Offered

Table 136. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. F.Hoffman La Roche Ltd Main Business

Table 138. F.Hoffman La Roche Ltd Latest Developments

Table 139. Novartis Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 140. Novartis Flu RNA Vaccines Product Offered

Table 141. Novartis Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Novartis Main Business

Table 143. Novartis Latest Developments

Table 144. Sinnovac Biotech Ltd Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 145. Sinnovac Biotech Ltd Flu RNA Vaccines Product Offered

Table 146. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Sinnovac Biotech Ltd Main Business

Table 148. Sinnovac Biotech Ltd Latest Developments

Table 149. Moderna Therapeutics Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 150. Moderna Therapeutics Flu RNA Vaccines Product Offered

Table 151. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Moderna Therapeutics Main Business

Table 153. Moderna Therapeutics Latest Developments

Table 154. CureVac Basic Information, Flu RNA Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 155. CureVac Flu RNA Vaccines Product Offered

Table 156. CureVac Flu RNA Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. CureVac Main Business

Table 158. CureVac Latest Developments

List of Figures

Figure 1. Picture of Flu RNA Vaccines

Figure 2. Flu RNA Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Flu RNA Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Flu RNA Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Flu RNA Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Non-Replicating mRNA

Figure 10. Product Picture of In Vivo Self-Replicating mRNA

Figure 11. Product Picture of In Vitro Dendritic Cell Non-Replicating mRNA Vaccine

Figure 12. Product Picture of Others

Figure 13. Global Flu RNA Vaccines Sales Market Share by Type in 2021

Figure 14. Global Flu RNA Vaccines Revenue Market Share by Type (2017-2022)

Figure 15. Flu RNA Vaccines Consumed in Hospitals

Figure 16. Global Flu RNA Vaccines Market: Hospitals (2017-2022) & (K Units)

Figure 17. Flu RNA Vaccines Consumed in Vaccination Center

Figure 18. Global Flu RNA Vaccines Market: Vaccination Center (2017-2022) & (K Units)

Figure 19. Flu RNA Vaccines Consumed in Specialized Clinics

Figure 20. Global Flu RNA Vaccines Market: Specialized Clinics (2017-2022) & (K Units)

Figure 21. Flu RNA Vaccines Consumed in Hospital Pharmacy

Figure 22. Global Flu RNA Vaccines Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 23. Flu RNA Vaccines Consumed in Others

Figure 24. Global Flu RNA Vaccines Market: Others (2017-2022) & (K Units)

Figure 25. Global Flu RNA Vaccines Sales Market Share by Application (2017-2022)

Figure 26. Global Flu RNA Vaccines Revenue Market Share by Application in 2021

Figure 27. Flu RNA Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Flu RNA Vaccines Revenue Market Share by Company in 2021

Figure 29. Global Flu RNA Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Flu RNA Vaccines Revenue Market Share by Geographic Region in 2021

Figure 31. Global Flu RNA Vaccines Sales Market Share by Region (2017-2022)

Figure 32. Global Flu RNA Vaccines Revenue Market Share by Country/Region in 2021

Figure 33. Americas Flu RNA Vaccines Sales 2017-2022 (K Units)

Figure 34. Americas Flu RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. APAC Flu RNA Vaccines Sales 2017-2022 (K Units)

Figure 36. APAC Flu RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Europe Flu RNA Vaccines Sales 2017-2022 (K Units)

Figure 38. Europe Flu RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Flu RNA Vaccines Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Flu RNA Vaccines Revenue 2017-2022 ($ Millions)

Figure 41. Americas Flu RNA Vaccines Sales Market Share by Country in 2021

Figure 42. Americas Flu RNA Vaccines Revenue Market Share by Country in 2021

Figure 43. United States Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Flu RNA Vaccines Sales Market Share by Region in 2021

Figure 48. APAC Flu RNA Vaccines Revenue Market Share by Regions in 2021

Figure 49. China Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Flu RNA Vaccines Sales Market Share by Country in 2021

Figure 56. Europe Flu RNA Vaccines Revenue Market Share by Country in 2021

Figure 57. Germany Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Flu RNA Vaccines Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Flu RNA Vaccines Revenue Market Share by Country in 2021

Figure 64. Egypt Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Flu RNA Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Flu RNA Vaccines in 2021

Figure 70. Manufacturing Process Analysis of Flu RNA Vaccines

Figure 71. Industry Chain Structure of Flu RNA Vaccines

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles